The Fauci/COVID-19 Dossier by Dr. David E. Martin

The document included in this post was sent to me by an anonymous source. It’s a technical and somewhat difficult read, but valuable information nonetheless.

It’s pretty evident that for a lengthy period, many interested parties have been trying to manipulate coronaviruses for the purpose of harming the public or for profiting monetarily. Visitors here can read the document below and see just how deep the rabbit hole goes.

I have written prior that scientists working for public and private sources have undoubtedly attempted to genetically manipulate these viral structures for nefarious purposes. Great amounts of funding have gone into these attempts to create and secure bioweapons against humanity.

In my considered opinion, the efforts to reach the above-referenced objective have fallen short. Because viral pathogens are too unpredictable and difficult to stabilize in lethal forms, it ultimately became easier for the controlling powers to fake a world pandemic than create one in real life.

— Dr. Reizer

Click on the image below to read the full PDF document:

David E. Martin, Ph.D.

Dr. David Martin is the founding CEO of M∙CAM Inc. M∙CAM is the international leader in intellectual property-based financial risk management. From auditing patent quality for governments and patent offices to providing state-of-the-art actuarial risk management systems and solutions to the largest banks and insurance companies, M∙CAM has established a global standard in patent quality and commercial validity assessment and management.

A spokesperson for global intellectual property accountability and quality reform, Dr. Martin has worked closely with the United States Congress, numerous trade and financial regulatory agencies in the United States, Europe, and Asia, in advocating and deploying infrastructure to support growing reliance on proprietary rights in business transactions. M∙CAM has supported the modernization of intellectual property, tax, and accounting laws through its work with oversight agencies and policymakers.

Dr. Martin has founded several for-profit and non-profit companies and organizations and serves on several boards. He was the founding CEO of Mosaic Technologies Inc., a company that developed and commercialized advanced computational linguistics technologies, dynamic data compression and encryption technologies, electrical field transmission technology, medical diagnostics, and stealth/anechoic technology. He was a founding member of Japan’s Institute for Interface Science & Technology. He founded and served as Executive Director of the Charlottesville Venture Group. He has served as a board member for the Research Institute for Small and Emerging Business (Washington D.C.), the Academy for Augmenting Grassroots Technological Innovations (India), the IST (Japan) the Charlottesville Regional Chamber of Commerce (Virginia), and the Charlottesville Industrial Development Agency (Virginia).

As a former Assistant Professor at the University of Virginia’s School of Medicine, Dr. Martin founded the University’s first wholly-owned, for-profit, research and development and technology transfer corporation. Engaged in domestic and international technology transfer, clinical research, and financing, this company pioneered new techniques of innovation management that have become industry standards. In 1999, Dr. Martin was appointed by the Governor of the Commonwealth of Virginia to serve on the Joint Commission on Technology and Science and has served the General Assembly and Virginia’s Center for Innovative Technology on numerous occasions.

Dr. Martin’s work with the Batten Institute at the Darden Graduate School of Business Administration at the University of Virginia and his related work at the Indian Institute for Management in Ahmedabad, India, has brought unprecedented curricular focus to areas of intangible asset risk management, finance, and accounting standards. In addition to his academic work, Dr. Martin has closely advised intellectual property-based finance and investment programs in India, China, Denmark, the European Union, the United Kingdom, South Africa, the Islamic Republic of Iran, the United States the United Arab Emirates.

Dr. Martin has publications in law, medicine, engineering, finance, and education. He maintains active research in the fields of linguistic genomics, fractal financial risk modeling, as well as continuing his over 15 years of research in cellular membrane ionic signaling.

______________________________________

The Target List Movie is Coming to Amazon Prime This Summer

In association with River Rose Productions, Mad Wife Productions has announced that The Target List movie will begin filming on April 10, 2021.

 Help Me Expose Big Pharma!

 

Visit The Target List IMDb Movie Page For Updates

Donations Are Greatly Appreciated!

$4,500.00 Generously Donated So Far! 

We are continuing our fundraising efforts for the movie. The movie production companies bringing this film to life have generously invested money into this project and have asked me to help them out by promoting a fundraiser to offset production expenses.

PLEASE CLICK HERE TO DONATE!

________________________________

PLEASE SIGN MY COVID-19 PETITION THAT REJECTS THE OFFICIAL NARRATIVE AND INVITATION TO TAKE THE VACCINE.

Next, screenshot your signed name on the petition platform, print a hardcopy, and keep it in a safe place.

PLEASE SIGN MY COVID-19 PETITION THAT REJECTS THE OFFICIAL NARRATIVE AND INVITATION TO TAKE THE VACCINE.

COVID-19 Jabs Are Gene Therapy Chemotherapy — Not Vaccines!

Dr. John Reizer

If we know anything about drugs, we know that all of these products come with risks to our health. Every drug that has ever been unleashed on healthcare consumers has accompanying product inserts with printed information about dosage and possible dangers associated with said products. There are also lengthy paragraphs written about adverse drug reactions. This is not earth-shattering news, and most people are aware of this information.

Some of the most serious drug reactions and adverse physiological effects concerning medicinal products are tagged to biologics and chemotherapy medicines. When you watch the ninety-second commercial for one of the products, two-thirds of the advertisement is devoted to the problems patients might encounter.

As dangerous as most drugs are, you don’t usually see videos posted on social media about people taking prescription and over-the-counter drugs and then having uncontrollable seizures and death afterward.

With vaccines and particularly the COVID-19 jabs, we are hearing about people having serious adverse reactions. And yes, people are dying from these vaccine products.

But, are the COVID-19 jabs vaccines?

I would argue that they are not vaccines because they do not confer immunity to recipients against a viral pathogen. We know this to be true because science has not identified or totally isolated a sars-cov-2 virus from a human or animal host.

By the vaccine-makers own admission, the COVID jabs are not creating immunity. The products are 95 percent effective in reaching two endpoints in subjects:

  1. The vaccines for two or three months will ensure patients are not testing positive when administered PCR tests.
  2. The vaccines for two or three months will offer patients that contract the illness a lessening of one of the symptoms associated with COVID-19.

Based on the limited clinical trials completed by the vaccine-makers, they have concluded that the COVID-19 jabs are ninety-five percent effective in reaching the two endpoints listed above. The endpoint goals speak more about the products being an antiviral medicine than they do a vaccine.

Gene Therapy Chemotherapy

David Martin, Ph.D., has made the case, and very well, I might add, that both Pfizer and Moderna’s claims that they have produced COVID-19 vaccines are inaccurate. Martin believes that the products created are, in fact, gene therapy chemotherapy. Watch the video below:

Dr. Martin suggests that if people knew they were being offered chemotherapy instead of a vaccine against an alleged viral pathogen, they would never line up and be eager to receive these hazardous products that do not confer immunity against any viral pathogen.

I agree with Dr. Martin one hundred percent.

______________________________________

THE TARGET LIST MOVIE IS COMING TO AMAZON PRIME, AND WE’RE ABOUT TO EXPOSE BIG PHARMA!

In association with River Rose Productions, Mad Wife Productions has announced that The Target List movie will begin filming on April 10, 2021.

 

The Target List is an action-thriller feature screenplay written by MJ Palo and John Reizer and is based on the novel, The Target List by John Reizer.

The Pilot Movie is a shorter version of the full feature screenplay written by MJ Palo and John Reizer.

Visit The Target List IMDb Movie Page

Directed by — Andrew Arguello and MJ Palo

First Assistant Director — Gregory Klino

Producer — MJ Palo

Executive Producer — John Reizer

Co-Executive Producers — Ryan BishopDavid R. DavisLisa HakesJames Richardson, and Robyn Richardson

Written by — MJ Palo and John Reizer

Cinematographer — Andrew Arguello

Editor — Andrew Arguello

Casting by — Justine Reyes

Production Assistant — Jennifer Bunn

Key Grip — Chris Casaceli

Gaffer — Max Georgeson

First Assistant Camera — Kellie Sasso

Production Staff — M.P. Poole

Special thanks — Louise Neufeld

INTRODUCING THE TARGET LIST CAST:

The Target List movie will be released in the summer of 2021 on Amazon Prime and other viewing platforms.

The Target List is a high-energy, fast-paced medical-action-thriller feature screenplay that uniquely combines the exciting elements and drama found in the hit films COMA and JACK REACHER.

It has a strong female protagonist and a cast of intriguing characters that provide nonstop action, dramatic effect, and the ability to drive the storyline towards a twist-ending. The Target List deals with the subject of cancer eradication and will be embraced by a broad audience that will instantly resonate with the many emotional elements associated with society’s ongoing battle to maintain health in the ever-increasing presence of new diseases.

The limited-location and limited-character setting allow a low-budget production. However, The Target List still belongs to the multi-million-dollar Hollywood action niche that is always looking for the next blockbuster and takes the audience on a 90-minute emotional and entertaining journey that leaves them yearning for a sequel.

Donations Are Greatly Appreciated!

We are only $1,050.00 away from our Goal!

We are continuing our fundraising efforts for the movie. The movie production companies bringing this film to life have generously invested money into this project and have asked me to help them out by promoting a fundraiser to offset production expenses.

PLEASE CLICK HERE TO DONATE!

Donation Perks:
–Donate $50 and receive an electronic copy of the book.
–Donate $100 and receive an e-book, Thank You credit, and a private link to online screening.
–Donate $200 and get an official The Target List poster, e-book, and private link to online screening OR
–Donate $200 and receive co-executive producer credit, an e-book, and a link to online screening.

Use of all donations:
We have already secured the necessary funding to execute this project and are looking for extra help to offset miscellaneous production expenses. All donations will be used exclusively for the production of the movie.

PLEASE CLICK HERE TO DONATE!

________________________________

PLEASE SIGN MY COVID-19 PETITION THAT REJECTS THE OFFICIAL NARRATIVE AND INVITATION TO TAKE THE VACCINE.

Next, screenshot your signed name on the petition platform, print a hardcopy, and keep it in a safe place.

PLEASE SIGN MY COVID-19 PETITION THAT REJECTS THE OFFICIAL NARRATIVE AND INVITATION TO TAKE THE VACCINE.